2021 VCI Editorial Calendar
Topics of Discussion:
Through expert interviews, discussions, and market analysis, DCAT Value Chain Insights provides need-to-know information to keep pace with a changing marketplace:
- The Global Pharma Watchlist: Tracking the performance of the global pharmaceutical industry and leading market sectors.
- The CDMO/CMO Report: Market analysis of the key developments and trends in pharmaceutical outsourcing.
- Manufacturing and Supply Lines: The latest in sourcing and the biopharmaceutical/ pharmaceutical manufacturing value chain.
- The Pharma Pulse: Senior executives share the leading issues on their radar and of import to the pharmaceutical industry.
Plus, Top Industry News: To help ensure DCAT members never miss the most important stories impacting the global biopharmaceutical/pharmaceutical manufacturing value chain, DCAT delivers each Friday, the week’s Top Industry News, a companion newsletter to DCAT Value Chain Insights that highlights the top news stories of the week.
Have questions? Contact DCAT’s Editorial Director, Patricia Van Arnum, pvanarnum@dcat.org, +1.609.208.1888 Ext 7014
DCAT Value Chain Insights 2021 Editorial Calendar: January–December 2021
| Issue Date | Topic |
| January 6 | The Global Pharma Watchlist: Global Pharma Outlook
Analysts provide an outlook on pharmaceutical industry performance for 2021 and beyond. |
| January 13 | The CDMO/CMO Report: The Year Ahead in Pharma Outsourcing
Pharma/biopharma outsourcing expert Jim Miller, Content Advisor/Consultant, DCAT, provides an outlook for bio/pharmaceutical outsourcing for 2021. |
| January 20 | Manufacturing and Supply Lines: Fine Chemicals The outlook for fine chemicals supply and demand. |
| January 27 | The Pharma Pulse: What is on the Horizon for 2021? Senior executives give their take on the issues most impactful to the industry for 2021. |
Top Industry News: Jan 8, 15, 22 and 29
|
February 3 |
The Global Pharma Watchlist: Biologics Analysis of the leading products and recent drug approvals for biologic-based drugs. |
| February 10 | The CDMO/CMO Report: Parenteral Drugs A roundup of expansion activity among CDMOs/CMOs for sterile manufacturing, aseptic fill-finish and lyophilization. |
| February 17 | Manufacturing and Supply Lines: API Sourcing
Industry roundtable on key trends/issues impacting sourcing for small-molecule active pharmaceutical ingredients (APIs) and intermediates. |
|
February 24 |
The Pharma Pulse: Re-shoring Drug Manufacturing Executives weigh in on policy proposals for re-shoring manufacturing respectively to the US and EU. |
Top Industry News: Feb. 5, 12, 19 and 26
|
March 3 |
The Global Pharma Watchlist: Blockbuster Muscle Analysis and market projections for new drugs, slated for market entry in 2021, with blockbuster potential. |
|
March 10 |
The CDMO/CMO Report: Packaging A roundup of expansions and technology advances in pharma packaging. |
|
March 17 |
Manufacturing and Supply Lines: Inside Big Pharma’s Manufacturing Networks The latest manufacturing expansion activity among the pharmaceutical majors. |
|
March 24 |
The Pharma Pulse: Artificial Intelligence and Supply Management Examining how digital tools, such as AI, are and potentially can be applied in supply management of APIs and drug products. |
|
March 31 |
Special Report: DCAT Benchmarking The results of DCAT’s latest benchmarking study examining topical issues in the pharma customer–supplier relationship. |
Top Industry News: Mar. 5, 12, 19, 26 and Apr. 2
|
April 7 |
The Global Pharma Watchlist: Generics Near-term market outlook for generic drugs. |
|
April 14 |
The CDMO/CMO Report: Biomanufacturing A roundup of expansion activity among CDMOs/CMOs in biomanufacturing. |
| April 21 | Manufacturing and Supply Lines: Small-molecule APIs
Supply and demand market overview for small-molecule active pharmaceutical ingredients (APIs). |
| April 28 | The Pharma Pulse: Emerging Pharma
Senior executives of bio/pharmaceutical start-ups and Emerging Pharma companies offer their views for successful product development. |
Top Industry News: Apr. 9, 16, 23 and 30
| May 5 | The Global Pharma Watchlist: Pharma in a Post-Brexit World
The impact of Brexit on the pharmaceutical industry. |
| May 12 | The CDMO/CMO Report: Solid-Dosage Drugs
The latest expansions and technology advances, including bioavailability enhancement, from CDMOs/CMOs in solid-dosage development and manufacturing. |
| May 19 | Manufacturing and Supply Lines: Continuous Manufacturing
The latest projects and technology advances in continuous anufacturing for APIs and drug products. |
| May 26 | The Pharma Pulse: Small Molecules and Biologics
Senior pharma executives weigh in on the evolving product mix between small molecules and biologics: current and future trends. |
Top Industry News: May 7, 14, 21 and 28
| June 2 | The Global Pharma Watchlist: Cell and Gene Therapies
Market outlook and manufacturing expansions for cell and gene therapies. |
| June 9 | The CDMO/CMO Report: What’s Trending in Pharma Outsourcing
Pharma/biopharma outsourcing expert Jim Miller, Content Advisor/Consultant, DCAT, analyzes key trends and developments in the CDMO/CMO sector. |
| June 16 | Manufacturing and Supply Lines: Clinical Trial Material Supply
Best practices to optimize clinical trial material supply. |
| June 23 | The Pharma Pulse: The Deal Makers
The top mergers and acquisitions thus far in 2021: the deal-makers and market impact. |
| June 30 | Special Report: New Drug Approvals in 2021
Analysis of the new molecular entity approvals thus far in 2021. |
Top Industry News: June 4, 11, 18, 25 and July 2
| July 7 | The Global Pharma Watchlist: India
Market overview and trends impacting pharmaceutical sourcing from India. |
| July 14 | Virtual DCAT Week, July 12–July 16, 2021, No issue |
| July 21 | Special Report: Virtual DCAT Week Review
Highlights from DCAT’s Member Company Announcement Forum and education programs at Virtual DCAT Week, including a bio/pharma industry outlook and executive insights on manufacturing/supply and drug development. |
| July 28 | The CDMO/CMO Report: Top 10 Moves Thus Far in 2021
A look at the top mergers and acquisitions and expansion news from CDMOs/CMOs thus far in 2021. |
Top Industry News: July 9, 16, 23 and 30
| August 4 | The Global Pharma Watchlist: Biosimilars
Market analysis and outlook for biosimilars. |
| August 11 | The CDMO/CMO Report: Formulation Development/Drug Product Manufacturing
Latest market and technological advances for solid-dosage and parenteral drugs. |
| August 18 | Manufacturing and Supply Lines: China
Market overview and trends impacting pharmaceutical sourcing from China. |
| August 25 | N/A: No issue |
Top Industry News: August 6, 13, 20 and 27
| September 1 | Global Pharma Watchlist: Small-molecule APIs
The top-selling small-molecule drugs and rising contenders. |
| September 8 | The CDMO/CMO Report: End-to-End Service Models
An inside-the-trenches view of the end-to-end service model: CDMOs/CMOs providing both drug-substance and drug-product development and manufacturing. |
| September 15 | Manufacturing and Supply Lines: Biomanufacturing
The latest capacity update and the industry’s fundamentals in biomanufacturing supply and demand. |
| September 22 | The Pharma Pulse: Precision Medicine and Manufacturing
Executives weigh in on manufacturing strategies for lower-volume drugs created by personalized medicines and more targeted therapies. |
| September 29 | Special Report: Global Pharma Pulse
Leading developments from the US, EU, China, India, and Central and South America. |
Top Industry News: September 3, 10, 17, 24 and Oct 1
| October 6 | The Global Pharma Watchlist: Top Pharma Deals in 2021
The leading mergers and acquisitions among pharmaceutical companies thus far in 2021. |
| October 13 | The CDMO/CMO Report: High-Potency Manufacturing
A roundup of recent expansions by CDMOs/CMOs and trends in high-potency manufacturing. |
| October 20 | Manufacturing and Supply Lines: API Sourcing
Industry roundtable on key trends/issues impacting sourcing for small-molecule active pharmaceutical ingredients (APIs) and intermediates. |
| October 27 | The Pharma Pulse: Project Management
Senior executives share case studies in innovation in project management with CDMOs/CMOs. |
Top Industry News: October 8, 15, 22 and 29
| November 3 | The Global Pharma Watchlist: The Key Pipeline Contenders
Late-stage drug candidates with strong market potential. |
| November 10 | The CDMO/CMO Report: Injectable Drugs
Industry roundtable on key trends and technological developments for injectable drugs, including drug-device technology. |
| November 17 | Manufacturing and Supply Lines: Biomanufacturing
The latest biomanufacturing expansions by the pharmaceutical majors. |
| November 24 | N/A: No Issue |
Top Industry News: November 5, 12, 19 and 26
| December 1 | The Global Pharma Watchlist: The Year in Review
A look at the top developments from 2021. |
| December 8 | The CDMO/CMO Report: The Movers and Shakers of 2021
A look at the top expansions and mergers/acquisitions from CDMOs/CMOs in 2021. |
| December 15 | Manufacturing and Supply Lines: Fine Chemicals
Market outlook and key trends in the chemical manufacturing value chain for intermediates and active pharmaceutical ingredients. |
Top Industry News: December 3, 10 and 17